Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis von Bieber, Thomas, Simpson, Eric L, Silverberg, Jonathan I, Thaçi, Diamant, Paul, Carle, Pink, Andrew E, Kataoka, Yoko, Chu, Chia-Yu, DiBonaventura, Marco, Rojo, Ricardo, Antinew, Jeremias, Ionita, Ileana, Sinclair, Rodney, Forman, Seth, Zdybski, Jacek, Biswas, Pinaki, Malhotra, Bimal, Zhang, Fan, Valdez, Hernan

Volltext

Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies von Chu, Chia-Yu

Volltext

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind,... von Guttman-Yassky, Emma, Teixeira, Henrique D, Simpson, Eric L, Papp, Kim A, Pangan, Aileen L, Blauvelt, Andrew, Thaçi, Diamant, Chu, Chia-Yu, Hong, H Chih-ho, Katoh, Norito, Paller, Amy S, Calimlim, Brian, Gu, Yihua, Hu, Xiaofei, Liu, Meng, Yang, Yang, Liu, John, Tenorio, Allan R, Chu, Alvina D, Irvine, Alan D

Volltext

New targets in treating granuloma annulare von Chu, Chia-Yu

Volltext

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System von Cho, Yung-Tsu, Yang, Che-Wen, Chu, Chia-Yu

Volltext

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis von Silverberg, Jonathan I., Guttman-Yassky, Emma, Thaçi, Diamant, Irvine, Alan D., Stein Gold, Linda, Blauvelt, Andrew, Simpson, Eric L., Chu, Chia-Yu, Liu, Zhuqing, Gontijo Lima, Renata, Pillai, Sreekumar G., Seneschal, Julien

Volltext

Keeping an eye on the ocular problems in dupilumab clinical trials von Chu, Chia‐Yu

Volltext

Ligelizumab for Chronic Spontaneous Urticaria von Maurer, Marcus, Giménez-Arnau, Ana M, Sussman, Gordon, Metz, Martin, Baker, Diane R, Bauer, Andrea, Bernstein, Jonathan A, Brehler, Randolf, Chu, Chia-Yu, Chung, Wen-Hung, Danilycheva, Inna, Grattan, Clive, Hébert, Jacques, Katelaris, Constance, Makris, Michael, Meshkova, Raisa, Savic, Sinisa, Sinclair, Rodney, Sitz, Karl, Staubach, Petra, Wedi, Bettina, Löffler, Jürgen, Barve, Avantika, Kobayashi, Kenneth, Hua, Eva, Severin, Thomas, Janocha, Reinhold

Volltext

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study von Maurer, Marcus, Giménez‐Arnau, Ana, Bernstein, Jonathan A., Chu, Chia‐Yu, Danilycheva, Inna, Hide, Michihiro, Makris, Michael, Metz, Martin, Savic, Sinisa, Sitz, Karl, Soong, Weily, Staubach, Petra, Sussman, Gordon, Barve, Avantika, Burciu, Alis, Hua, Eva, Janocha, Reinhold, Severin, Thomas

Volltext

Burden of atopic dermatitis in Asia von Tsai, Tsen‐Fang, Rajagopalan, Murlidhar, Chu, Chia‐Yu, Encarnacion, Lonabel, Gerber, Robert A., Santos‐Estrella, Paul, Llamado, Lyndon John Q., Tallman, Anna M.

Volltext

Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein von Cho, Yung-Tsu, Lee, Chih-Hung, Lee, Jing-Yi, Chu, Chia-Yu

Volltext

Changing trends of contact allergens: A 40‐year retrospective study from a referral centre in northern Taiwan von Lin, Pin‐Hsin, Tseng, Yu‐Hsian, Chu, Chia‐Yu

Volltext

Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results von Maurer, Marcus, Giménez-Arnau, Ana, Ensina, Luis Felipe, Chu, Chia-Yu, Jaumont, Xavier, Tassinari, Paolo

Volltext

Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit von Cho, Yung-Tsu, Lin, Yi-Tsz, Yang, Che-Wen, Chu, Chia-Yu

Volltext

Treatments for Severe Cutaneous Adverse Reactions von Cho, Yung-Tsu, Chu, Chia-Yu

Volltext

Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer von Chu, Chia‐Yu, Choi, Jennifer, Eaby‐Sandy, Beth, Langer, Corey J., Lacouture, Mario E.

Volltext

Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan von Chen, Yi-Chun, MD, Chang, Chia-Ying, MD, Cho, Yung-Tsu, MD, Chiu, Hsien-Ching, MD, Chu, Chia-Yu, MD, PhD

Volltext

Purpuric drug eruptions induced by EGFR tyrosine kinase inhibitors are associated with IQGAP1‐mediated increase in vascular permeability von Sheen, Yi‐Shuan, Lin, Ming‐Hsien, Tzeng, Wen‐Chia, Chu, Chia‐Yu

Volltext

Targeting the cutaneous microbiota in atopic dermatitis: ‘A new hope’ or ‘attack of the CoNS’? von Chu, Chia‐Yu

Volltext

Insulin‐like growth factor 2 mRNA‐binding protein 3 enhanced melanoma migration through regulation of AKT1 and RELA expression von Sheen, Yi‐Shuan, Syu, Yan‐Jie, Chang, Yu‐Chuan, Hsieh, Ping‐Han, Liao, Yi‐Hua, Lin, Ming‐Hsien, Chen, Chien‐Yu, Chu, Chia‐Yu, Chu, Chia‐Ying

Volltext